These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8861795

  • 1. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
    Inaba S, Tanizawa T, Takahashi T, Ishihara S, Arai M, Sakai Y, Kurose KK, Matsukura H, Okada T.
    Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K, Nakamura S, Moriya S, Koshino H, Iwasaki N, Motoyama O, Sakai T.
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M, Koike H, Han GD, Shimizu F, Kawachi H.
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
    Iitaka K, Moriya S, Nakamura S, Tomonaga K, Sakai T.
    Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
    [Abstract] [Full Text] [Related]

  • 6. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
    Iitaka K, Yamamoto A, Ogawa N, Sekine T, Tamai S, Motoyama O.
    Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IgG-associated primary glomerulonephritis in children.
    Yoshikawa N, Iijima K, Shimomura M, Nakamura H, Ito H.
    Clin Nephrol; 1994 Nov; 42(5):281-7. PubMed ID: 7851027
    [Abstract] [Full Text] [Related]

  • 9. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
    Ter Arkh; 2002 Nov; 74(6):11-8. PubMed ID: 12136475
    [Abstract] [Full Text] [Related]

  • 10. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
    Arikan H, Koc M, Cakalagaoglu F, Tuglular S, Ozener C, Akoglu E.
    Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
    [Abstract] [Full Text] [Related]

  • 11. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W, Long C, Zhigang Z, Feng J, Muyi G.
    Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
    [Abstract] [Full Text] [Related]

  • 12. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ.
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [Abstract] [Full Text] [Related]

  • 13. Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.
    Kazama I, Matsubara M, Ejima Y, Michimata M, Suzuki M, Miyama N, Sato A, Sato H, Ito S.
    Clin Exp Nephrol; 2005 Mar; 9(1):62-8. PubMed ID: 15830276
    [Abstract] [Full Text] [Related]

  • 14. Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children.
    Takeda A, Niimura F, Matsutani H.
    Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):330-5. PubMed ID: 7666598
    [Abstract] [Full Text] [Related]

  • 15. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
    Srp Arh Celok Lek; 1999 Jun; 127(5-6):163-71. PubMed ID: 10500423
    [Abstract] [Full Text] [Related]

  • 16. A quantitative analysis of the mesangium in children with IgA nephropathy: sequential study.
    Suzuki J, Yoshikawa N, Nakamura H.
    J Pathol; 1990 May; 161(1):57-64. PubMed ID: 2370599
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 18. [Evolution of morphological and clinical changes in mesangial proliferative glomerulonephritis].
    Danilewicz M, Kałuzyński A, Wagrowska-Danilewicz M, Bechcińska B, Zabicka H.
    Wiad Lek; 1992 Jun; 45(11-12):433-5. PubMed ID: 1279900
    [Abstract] [Full Text] [Related]

  • 19. [Prominent subepithelial deposits detected on 2nd renal biopsy in a boy with membranoproliferative glomerulonephritis type I: a case report].
    Motoyama O, Ohshima M, Kawamura S, Iitaka K.
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):247-52. PubMed ID: 7602812
    [Abstract] [Full Text] [Related]

  • 20. Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
    Ferrario F, Rastaldi MP.
    J Nephrol; 2004 Apr; 17(4):483-6. PubMed ID: 15372408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.